Cite
Dushar M, Nowaczyk J, Pyrżak B, et al. Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father. Eur J Med Genet. 2021;64(12):104368doi: 10.1016/j.ejmg.2021.104368.
Dushar, M., Nowaczyk, J., Pyrżak, B., Akopyan, H., Śmigiel, R., Walczak, A., Rydzanicz, M., Płoski, R., & Szczałuba, K. (2021). Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father. European journal of medical genetics, 64(12), 104368. https://doi.org/10.1016/j.ejmg.2021.104368
Dushar, Marya, et al. "Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father." European journal of medical genetics vol. 64,12 (2021): 104368. doi: https://doi.org/10.1016/j.ejmg.2021.104368
Dushar M, Nowaczyk J, Pyrżak B, Akopyan H, Śmigiel R, Walczak A, Rydzanicz M, Płoski R, Szczałuba K. Efficacy and safety of sirolimus therapy in familial hypoinsulinemic hypoglycemia caused by AKT2 mutation inherited from the mosaic father. Eur J Med Genet. 2021 Dec;64(12):104368. doi: 10.1016/j.ejmg.2021.104368. Epub 2021 Oct 18. PMID: 34673243.
Copy
Download .nbib